Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 101 | — | MONOPAR THERAPEUTICS INC | — | 5,474.0 | $507K | 0.12% | +2K | +49.8% | $92.59 | — |
| 102 | FDMT | 4D MOLECULAR THERAPEUTICS IN | Healthcare | 37,055.0 | $493K | 0.12% | +12K | +47.3% | $13.30 | +5.8% |
| 103 | — | APOGEE THERAPEUTICS INC | — | 3,705.0 | $492K | 0.12% | +167.0 | +4.7% | $132.73 | — |
| 104 | FSCO | FS CREDIT OPPORTUNITIES CORP | Financial Services | 96,005.0 | $479K | 0.11% | +4K | +4.5% | $4.99 | +2.3% |
| 105 | JBIO | JADE BIOSCIENCES INC | Healthcare | 21,329.0 | $474K | 0.11% | +3K | +17.2% | $22.22 | +3.7% |
| 106 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 19,304.0 | $468K | 0.11% | +5K | +35.0% | $24.26 | +10.8% |
| 107 | MGTX | MEIRAGTX HLDGS PLC | Healthcare | 34,119.0 | $461K | 0.11% | +4K | +11.6% | $13.51 | +2.3% |
| 108 | PVLA | PALVELLA THERAPEUTICS INC NE | Healthcare | 3,007.0 | $460K | 0.11% | +242.0 | +8.8% | $152.82 | -0.4% |
| 109 | BCAX | BICARA THERAPEUTICS INC | Healthcare | 15,086.0 | $448K | 0.10% | +331.0 | +2.2% | $29.69 | -16.5% |
| 110 | VKTX | VIKING THERAPEUTICS INC | Healthcare | 11,381.0 | $444K | 0.10% | +4K | +54.8% | $39.01 | -14.9% |
| 111 | — | ATAIBECKLEY INC | — | 83,469.0 | $440K | 0.10% | +20K | +31.3% | $5.27 | — |
| 112 | KYMR | KYMERA THERAPEUTICS INC | Healthcare | 3,795.0 | $435K | 0.10% | +755.0 | +24.8% | $114.67 | +4.4% |
| 113 | PRME | PRIME MEDICINE INC | Healthcare | 117,909.0 | $435K | 0.10% | +51K | +77.3% | $3.69 | -16.9% |
| 114 | CGEM | CULLINAN THERAPEUTICS INC | Healthcare | 23,883.0 | $435K | 0.10% | +1K | +4.4% | $18.21 | +14.9% |
| 115 | GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | 17,944.0 | $434K | 0.10% | +1K | +7.3% | $24.20 | -37.8% |
| 116 | — | BIOHAVEN LTD | — | 29,007.0 | $432K | 0.10% | +5K | +22.6% | $14.88 | — |
| 117 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 39,565.0 | $428K | 0.10% | +10K | +36.1% | $10.83 | +26.2% |
| 118 | XNCR | XENCOR INC | Healthcare | 26,537.0 | $427K | 0.10% | +10K | +60.8% | $16.10 | +52.9% |
| 119 | SANA | SANA BIOTECHNOLOGY INC | Healthcare | 122,089.0 | $426K | 0.10% | +69K | +130.1% | $3.49 | +3.9% |
| 120 | RCUS | ARCUS BIOSCIENCES INC | Healthcare | 13,748.0 | $424K | 0.10% | +1K | +8.6% | $30.83 | -4.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
36.7%
Technology
15.7%
Financial Services
15.3%
Industrials
13.0%
Consumer Cyclical
5.8%
Energy
4.7%
Real Estate
2.8%
Utilities
1.7%
Communication Services
1.7%
Basic Materials
1.5%